Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Non-Hodgkin 6Recurrence 5Lymphoma, Mantle-Cell 5Lymphoma 5Lymphoma, B-Cell 4Dendritic Cell Sarcoma, Interdigitating 2Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Cytokine Release Syndrome 1Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

glofitamab 2Cyclophosphamide 2pembrolizumab 1obinutuzumab 1fludarabine phosphate 1Whole-Body Irradiation 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Gemcitabine 1Etoposide 1Cyclosporine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × glofitamab × 90 days × Clear all
NCT04889716 2026-05-26

CAR-T Followed by Bispecific Antibodies

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
23 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT06481826 2026-03-27

Glofitamab in Chinese Patients With R/R DLBCL

Peking Union Medical College Hospital

Recruiting
20 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡